Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center
- 1 August 2004
- journal article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 3 (3) , 159-163
- https://doi.org/10.1016/j.jcf.2004.03.010
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosaThe Lancet, 2001
- Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensusEuropean Respiratory Journal, 2000
- Molecular Epidemiology of Community‐AcquiredStaphylococcus aureusin Families with and without Cystic Fibrosis PatientsThe Journal of Infectious Diseases, 2000
- Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centreJournal of Hospital Infection, 1998
- Distribution and transmission ofPseudomonas aeruginosa andBurkholderia cepacia in a hospital wardPediatric Pulmonology, 1996
- The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and BritainNature Medicine, 1995
- Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosisThe Lancet, 1993
- Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patientsAPMIS, 1993
- Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.Thorax, 1990
- Colonization of the Respiratory Tract with Pseudomonas cepacia in Cystic FibrosisChest, 1987